The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer’s Disease

The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer’s Disease

Background: Vascular risk factors (VRF) may influence response to rivastigmine in Alzheimer’s disease (AD). Methods: AD patients who participated in a randomized, double-blind, placebo-controlled trial of rivastigmine patch and capsule treatment were stratified by baseline VRF status. Treatment resp...

Full description

Bibliographic Details
Main Authors: M.R. Farlow, P.M. Doraiswamy, X. Meng, K. Cooke, M. Somogyi
Format: Article
Language:English
Published: Karger Publishers 2011-06-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Alzheimerߣs disease
Efficacy
Rivastigmine
Transdermal patch
Vascular risk factors
Online Access:http://www.karger.com/Article/FullText/328745

Internet

http://www.karger.com/Article/FullText/328745

Similar Items